FDA Approved: TYENNE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Polyarticular Juvenile Idiopathic Arthritis
• Rheumatoid Arthritis
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• TYENNE (TOCILIZUMAB-AAZG)

Snippet

ORIG AP for TYENNE (TOCILIZUMAB-AAZG)